Staphylococcus aureus, epithelial disruption, and nasal polyps: Are we one step ahead in combatting this foe? - 07/02/19
Doi : 10.1016/j.jaci.2018.11.021
Mahboobeh Mahdavinia, MD, PhD a, c, Pete S. Batra, MD, FACS b, c, ⁎ 
a Division of Allergy/Immunology, Department of Internal Medicine, Chicago, Ill
b Department of Otorhinolaryngology–Head and Neck Surgery, Chicago, Ill
c Rush Center for Airway Diseases, Rush University Medical Center, Chicago, Ill
∗Corresponding author: Pete S. Batra, MD, FACS, Otorhinolaryngology–Head and Neck Surgery, Rush University Medical Center, 1611 W Harrison St, Suite 550, Chicago, IL 60612.Otorhinolaryngology–Head and Neck SurgeryRush University Medical Center1611 W Harrison St, Suite 550ChicagoIL60612
Key words : Chronic rhinosinusitis, Staphylococcus aureus, Rho-associated protein kinase inhibitor, nasal polyp, epithelium
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: M. Mahdavinia and P. S. Batra have received a research grant from Medtronic. P. S. Batra has previously served on the advisory board for Sanofi Regeneron and Optinose and received royalties from Springer. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 143 - N° 2
P. 563-564 - février 2019 Retour au numéro
Article précédent
- Awaiting allograft antigen: For rejection or tolerance?
- Tomoaki Ando, Toshiaki Kawakami
- A natural killer T-cell subset that protects against airway hyperreactivity
- Ya-Ting Chuang, Krystle Leung, Ya-Jen Chang, Rosemarie H. DeKruyff, Paul B. Savage, Richard Cruse, Christophe Benoit, Dirk Elewaut, Nicole Baumgarth, Dale T. Umetsu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?